Showing promise in the field of excess body fat treatment, retatrutide is a unique strategy. Beyond many existing medications, retatrutide operates as a double agonist, simultaneously affecting both GLP-like peptide-1 (GLP-1) and glucose-responsive insulinotropic hormone (GIP) binding sites. This concurrent activation promotes several beneficial ef